link to RWJMS home page
Banner Image Here

Research

Publications

Peer-Reviewed Articles

Ciaccio EJ, Biviano AB, Whang W, Wit AL, Garan H, Coromilas J: New methods for estimating local electrical activation rate during atrial fibrillation. Heart Rhythm 6: 21-32, 2009.  

Tung R, Sklyar E, Josephson M. An unusual form of preexcitation: fasciculoventricular bypass tract. Heart Rhythm. 2008 Dec;5(12):1767-8

Sabnani I, Zucker MJ, Rosenstein ED, Baran DA, Arroyo LH, Tsang P, Zubair M, Rivera V. A novel therapeutic approach to the treatment of scleroderma-associated pulmonary complications: safety and efficacy o combination therapy with imatinib and cyclophosphamide. Rheumatology (Oxford). 2009 Jan; 48(1):49-52, PMID:18815156

Tinker LF, Bonds DE, Margolis, et al (JB Kostis Collaborator); Women’s Health Initiative. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women:  the Women’s Health Initiative randomized controlled dietary modification trial. Arch Intern 168(14):1500-1511, 2008.

Brunner RL, Cochrane B, Jackson RD, et al (JB Kostis Collaborator); Women’s Health Initiative Investigators. Calcium, vitamin D supplementation, and physical function in the Women’s Health Initiative. J Am Diet Assoc 108(9):1472-1479, 2008.

Sharma R, Kostis WJ, Wilson AC, Cosgrove NM, Hassett AL, Moreyra AE, Delnevo CD, Kostis JB. Questionable hospital chart documentation practices by physicians. J Gen Intern Med 23(11):1865-1870, 2008.

Ritenbaugh C, Stanford JL, Wu L, Shikany JM, Schoen RE, Stefanick ML, Taylor V, Garland C, Frank G, Lane D, Mason E, McNeeley SG, Ascensao J, Chlebowski RT:  The Women’s Health Initiative randomized clinical trial.  (JB Kostis Collaborator). Conjugated equine estrogens and colorectal cancer incidence and survival:  The Women’s Health Initiative randomized clinical trial. Cancer Epidemiol Biomarkers Prev 17;(10):2609-2618, 2008.

Turnbull F, Woodward M, Neal B, Barzi F, Ninomiya T, Chalmers J, Perkovic V, Li N, MacMahon S. for the Blood Pressure Lowering Treatment Trialists’ Collaboration  (JB Kostis, member). Do men and women respond differently to blood pressure lowering treatment?  Results of prospectively-designed overviews of randomized trials.  European Heart J 29(21):2669-2680, 2008.

Davis BR, Kostis JB, Simpson LM, et al. for the ALLHAT Collaborative Research Group.  Heart failure with preserved and reduced left ventricular ejection fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Circulation 118:2259-2267, 2008.

Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T, Rossouw J, Lane D, O’Sullivan MJ, Yasmeen S, Hiatt RA, Shikany JM, Vitolins M, Khandekar J, Hubbell FA; Women’s Health Initiative Investigators (JB Kostis Collaborator). Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst 100(22):1581-1591, 2008.

Chlebowski RT, Kuller LH, Prentice RL, Stefanick ML, Manson JE, Gass M, Aragaki AK, Ockene JK, Lane DS, Sarto GE, Rajkovic A, Schenken R, Hendrix SL, Ravdin PM, Rohan TE, Yasmeen S, Anderson G; WHI Investigators (JB Kostis Collaborator). Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med 360(6):573-587, 2009.

The Fibrinogen Studies Collaboration (JB Kostis, member). Measures to assess the prognostic ability of the stratified Cox proportional hazards model. Statistics in Medicine 28(3):389-411, 2009.

The Fibrinogen Studies Collaboration (JB Kostis, member). Correcting for multivariate measurement error by regression calibration in meta-analyses of epidemiological studies. Statistics in Medicine 28(7):1067-1092, 2009. (PMID: 19222086)

The Fibrinogen Studies Collaboration (JB Kostis, member). Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Statistics in Medicine 28(8); 1218-1237, 2009. (PMID: 19222087)

Berger JS, Brown DL, Burke GL, Oberman A, Kostis JB, Langer RD, Wong ND, Wassertheil-Smoller S. Aspirin use, dose, and clinical outcomes in postmenopausal women with stable cardiovascular disease. Circulation:  Cardiovascular Quality and Outcomes 2;78-87, 2009.

James E Skinner, Michael Meyer, William C. Dalsey, Brian A. Nester, George Ramalanjaona, Brian J O'Neil, Antoinette Mangione, Carol Terregino, Abel Moreyra, Daniel N Weiss, Jerry M Anchin, Una Geary, Pamela Taggart.  “Risk Stratification for Arrhythmic Death in an Emergency Department Cohort: a new Oct;156(4):776-82.method of nonlinear PD2i analysis of the ECG” Therapeutics and Clinical Risk Management 2008 4(4) 689-697.

Rudnick MR, Davidson C, Laskey W, Stafford JL, Sherwin PF; VALOR Trial Investigators. (Collaborators (38) Bottner R, Cambier P, Clark V, Davidson C, DeGent G, Douglas J, Eways E, Farrell P, Fenves A, Fung A, Gellman J, Hanks WE, Hillegas W, Khosla S, Kingsley E, LaMarche N, Mann T, Markarian M, McFalls E, McGeehin F, Moreyra A, Nader R, O'Bryan J, O'Meallie L, Papadakos S, Piana R, Puildo J, Rohrbeck S, Rudnick M, Rusterholtz L, Schaer G, Shunk K, Stafford JL, Tobis J, Vernace M, Weiland F, Weinstein I, Williams D. Am Heart J. 2008 Oct;156(4):776-82.  Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial.

 

Body text place holder

 

Publications Archive
Click Here to browse the Publications Archive